MechanismsTherapeuticsCancer Drug ResistanceNeurodegenerative

Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment

Cell Death Discovery

Abstract

NRF2 is regulated through post-translational modifications (PTMs) and epigenetic alterations. PTMs including phosphorylation, ubiquitination, and acetylation modulate NRF2's stability, activity, and localization. Epigenetic modifications including DNA methylation, histone modifications, and non-coding RNAs regulate NRF2 expression.

Key Findings

  • NRF2 stability controlled by phosphorylation, ubiquitination, acetylation
  • Epigenetic modifications regulate NRF2 expression
  • DNA methylation of NRF2 promoter represses expression
  • Roadmap for PTM-targeted NRF2 therapies

Clinical Significance

Opens new therapeutic dimensions by mapping complete regulatory landscape of NRF2.

Citation

Yang, X. et al. (2025). Epigenetic and PTM modifications of NRF2. Cell Death Discovery.

DOI: 10.1038/s41420-025-02491-z